The pharmaceutical industry's expansion is being propelled by factors like improved healthcare accessibility and advancements in nanotechnology and generative AI for drug discovery. Therefore, I believe value investors could consider pharma stocks Merck & Co., Inc. (MRK), Astellas Pharma Inc. (ALPMY), and Taro Pharmaceutical Industries Ltd. (TARO), which seems to be trading at a discount.
The growing aging population and chronic diseases fuel the pharma industry’s growth. Moreover, the improvements in purchasing power and access to quality healthcare for poor and middle-class families worldwide also are driving the development of the global pharma industry.
